Literature DB >> 20737218

Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.

Douglas B Evans, Beth A Erickson, Paul Ritch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20737218     DOI： 10.1245/s10434-010-1285-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  16 in total

Review 1.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

Authors:  Kathleen K Christians; Susan Tsai; Anna Mahmoud; Paul Ritch; James P Thomas; Lauren Wiebe; Tracy Kelly; Beth Erickson; Huamin Wang; Douglas B Evans; Ben George
Journal:  Oncologist       Date:  2014-02-25

3.  Imaging of pancreatic ductal adenocarcinoma: State of the art.

Authors:  Eric Peter Tamm; Priya Ranjit Bhosale; Raghu Vikram; Leonardo Pimentel de Almeida Marcal; Aparna Balachandran
Journal:  World J Radiol       Date:  2013-03-28

4.  Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study.

Authors:  Joal D Beane; Kayla F Griffin; Elliot B Levy; Prakash Pandalai; Bradford Wood; Nadine Abi-Jaoudeh; Tatiana Beresnev; Yvonne Shutack; Carole C Webb; Itzhak Avital; Udo Rudloff
Journal:  Invest New Drugs       Date:  2014-09-19       Impact factor: 3.850

5.  A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.

Authors:  Matthew E Burge; Nick O'Rourke; David Cavallucci; Richard Bryant; Alessandra Francesconi; Kathleen Houston; David Wyld; Melissa Eastgate; Robert Finch; George Hopkins; Paul Thomas; David Macfarlane
Journal:  HPB (Oxford)       Date:  2015-04-30       Impact factor: 3.647

Review 6.  Advanced-stage pancreatic cancer: therapy options.

Authors:  Jens Werner; Stephanie E Combs; Christoph Springfeld; Werner Hartwig; Thilo Hackert; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2013-04-30       Impact factor: 66.675

Review 7.  Pancreatic cancer-improved care achievable.

Authors:  Trond A Buanes
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

8.  Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.

Authors:  Vikas Dudeja; Edward W Greeno; Sidney P Walker; Eric H Jensen
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

9.  Preoperative imaging for resectable periampullary cancer: clinicopathologic implications of reported radiographic findings.

Authors:  Zhi Ven Fong; Wei Phin Tan; Harish Lavu; Eugene P Kennedy; Donald G Mitchell; Leonidas G Koniaris; Patricia K Sauter; Ernest L Rosato; Charles J Yeo; Jordan M Winter
Journal:  J Gastrointest Surg       Date:  2013-04-04       Impact factor: 3.452

10.  Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer.

Authors:  Nguyen H Tran; Vaibhav Sahai; Kent A Griffith; Hari Nathan; Ravi Kaza; Kyle C Cuneo; Jiaqi Shi; Edward Kim; Christopher J Sonnenday; Clifford S Cho; Theodore S Lawrence; Mark M Zalupski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-09-05       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.